Our 2025 Spring Research Update Meeting took place at BMA House, home of the British Medical Association, in Tavistock Square, London on 24 March where we invited guests to an inspiring agenda of some of the most up to date news of our funded research.
Theme: Investigating Ambroxol: a pivotal next step in the search for Parkinson’s treatments
Our latest meeting focused on updates from the phase 3 clinical trial for ambroxol, which began this spring. Attendees also heard from PD Frontline,a remote study offering online genetic testing for people with Parkinson’s, about the pathways to getting involved in future clinical trials through the platform.
Agenda
Cure Parkinson’s Spring Research Update 2025 – Dr Simon Stott
ASPro-PD: Phase 3 Trial of Ambroxol – Dr Marco Toffoli, Mairead Cullen, Prof Anthony Schapira
Testing iLCT-evaluated compounds in patient-derived neurons – Dr Francesco Capriglia
An Introduction to the UK Parkinson’s Disease Clinical Study Group – Emma Fargher
PD Frontline: Genetic Testing for Parkinson’s – Amelia Anderson, Georgia Pittwood
Panel discussion and Q&A
